Cargando…

Hepatic Involvement in Systemic Sarcoidosis

Patient: Female, 68 Final Diagnosis: Hepatic sarcoidosis Symptoms: Abdominal pain • nausea • weakness Medication: — Clinical Procedure: Liver biopsy Specialty: Gastroenterology and Hepatology OBJECTIVE: Rare disease BACKGROUND: Sarcoidosis is a systemic disease that can affect any organ, including t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Abdisamad M., Bhandari, Bishal, Soriano, Paolo K., Quader, Zafar, Gao, John Z., Shuster, Dmitry, Mamillapalli, Chaitanya K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196583/
https://www.ncbi.nlm.nih.gov/pubmed/30305603
http://dx.doi.org/10.12659/AJCR.910600
Descripción
Sumario:Patient: Female, 68 Final Diagnosis: Hepatic sarcoidosis Symptoms: Abdominal pain • nausea • weakness Medication: — Clinical Procedure: Liver biopsy Specialty: Gastroenterology and Hepatology OBJECTIVE: Rare disease BACKGROUND: Sarcoidosis is a systemic disease that can affect any organ, including the liver. It is manifested by the presence of non-caseating granulomas within involved organs, most commonly the pulmonary, lymphatic, and hepatic system. Unlike pulmonary or lymphatic involvement, hepatic involvement is usually asymptomatic and it is underdiagnosed. Here, we report a case of a patient with a history of pulmonary sarcoidosis who developed hepatic sarcoidosis. CASE REPORT: 68-year-old female with pulmonary sarcoidosis with a 2-week history of severe abdominal pain and epigastric tenderness presented to our center. Abdominal magnetic resonance imaging (MRI) demonstrated mild hepatic fibrosis and cirrhosis. A thorough workup was performed including a liver biopsy which showed chronic non-necrotizing granulomas consistent with sarcoidosis. She was started on prednisone and subsequently improved. The patient was symptom-free on follow-up 1 month later. CONCLUSIONS: The majority of patients with hepatic sarcoidosis are usually asymptomatic, with only 5–30% presenting with abdominal pain, jaundice, nausea, vomiting, and hepatosplenomegaly. In rare cases, hepatic sarcoidosis can lead to cholestasis, portal hypertension, cirrhosis, or Budd-Chiari syndrome. Treatment with steroids is the mainstay of therapy; however, in severe cases, patients may require liver transplantation. This case report demonstrates that hepatic sarcoidosis is a serious condition, and if not treated, can lead to portal hypertension and cirrhosis. In patients with sarcoidosis, early detection and longitudinal follow-up is important in preventing overt liver failure.